Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Accounts Payables (2021 - 2025)

Medicinova (MNOV) has disclosed Accounts Payables for 8 consecutive years, with $624995.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables changed N/A to $624995.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $624995.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $624995.0 for FY2025, N/A changed from the prior year.
  • Accounts Payables for Q4 2025 was $624995.0 at Medicinova, down from $745958.0 in the prior quarter.
  • The five-year high for Accounts Payables was $1.0 million in Q4 2023, with the low at $402740.0 in Q4 2021.
  • Average Accounts Payables over 5 years is $647507.7, with a median of $642526.0 recorded in 2021.
  • The sharpest move saw Accounts Payables skyrocketed 55.38% in 2022, then decreased 14.71% in 2025.
  • Over 5 years, Accounts Payables stood at $402740.0 in 2021, then skyrocketed by 37.24% to $552720.0 in 2022, then surged by 81.64% to $1.0 million in 2023, then dropped by 29.46% to $708203.0 in 2024, then dropped by 11.75% to $624995.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $624995.0, $745958.0, and $569445.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.